Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
Prepare for some unpleasant side effects from COVID-19 shots

Prepare for some unpleasant side effects from COVID-19 shots

Kaiser Health News | 
Data from early trials of several COVID-19 vaccines suggests that consumers will need to be prepared for side effects that, ...
couldinterfe

‘Like a fire alarm and a sprinkler system all in one’: Immune proteins keep some COVID patients from getting seriously ill

Genetic Literacy Project | 
Dr. Megan Ranney has learned a lot about COVID-19 since she began treating patients with the disease in the emergency ...
covid vaccine

US appears ill-prepared to support COVID vaccine rollout

Medscape | 
In a four-page memo this summer, the federal Centers for Disease Control and Prevention told health departments across the country to draft ...
unnamed file

‘Overwhelmingly positive’: Fauci says ‘independent board’ has authority to end vaccine trials early and roll out immunizations

CNN | 
Although two ongoing clinical trials of 30,000 volunteers are expected to conclude by the end of the year, [Anthony] Fauci ...
max scherzer nationals

Unproven stem cell treatments gain popularity boost from Max Scherzer, Tiger Woods, other pro athletes

Washington Post | 
Stem cells and related therapies, such as platelet injections, have been used for the past decade by top athletes: golfer ...
fg logo

Viewpoint: Precision medicine promises a lot, but has delivered little

New York Times | 
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about ...
drugpricesmall

Breakthrough Novartis ‘living cell’ leukemia drug to debut but at $650,000 per treatment

Scientific American | 
When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like “breakthrough,” “revolutionary” and “a watershed ...
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.